Back
Protagonist Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$81.51
Seasonality Move:
6.39%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
Protagonist Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.33 | Sell |
| 20-day SMA: | 83.02 | Sell |
| 50-day SMA: | 85.46 | Sell |
| 200-day SMA: | 67.01 | Buy |
| 8-day EMA: | 76.34 | Buy |
| 20-day EMA: | 52.58 | Buy |
| 50-day EMA: | 27.42 | Buy |
| 200-day EMA: | 7.91 | Buy |
Protagonist Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.84 | Buy |
| Relative Strength Index (14 RSI): | 46.2 | Sell |
| Chaikin Money Flow: | -269951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (81.05 - 84.35) | Sell |
| Bollinger Bands (100): | (73.25 - 88.77) | Buy |
Protagonist Therapeutics, Inc. Technical Analysis
| Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics, Inc. Stock
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 81.93 while PTGX 8-day simple moving average is 83.33, which is a Sell signal.
-
The stock price of PTGX is 81.93 while Protagonist Therapeutics, Inc. 20-day SMA is 83.02, which makes it a Sell.
-
Protagonist Therapeutics, Inc. 50-day simple moving average is 85.46 while PTGX share price is 81.93, making it a Sell technically.
-
PTGX stock price is 81.93 and Protagonist Therapeutics, Inc. 200-day simple moving average is 67.01, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
35
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Is Protagonist Therapeutics, Inc. a Buy or a Sell?
-
Protagonist Therapeutics, Inc. stock is rated a SellThe current Protagonist Therapeutics, Inc. [PTGX] share price is $81.93. The Score for PTGX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics, Inc. Stock Info
Market Cap:
5.1B
Price in USD:
81.93
Share Volume:
352.5K
Protagonist Therapeutics, Inc. 52-Week Range
52-Week High:
96.54
52-Week Low:
33.70
Sell
35
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Protagonist Therapeutics, Inc. Share Price Forecast
-
What is the Protagonist Therapeutics, Inc. stock price today?The Protagonist Therapeutics, Inc. stock price is 81.93 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics, Inc. is overvalued.
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 81.93 while PTGX 8-day exponential moving average is 76.34, which is a Buy signal.
-
The stock price of PTGX is 81.93 while Protagonist Therapeutics, Inc. 20-day EMA is 52.58, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day exponential moving average is 27.42 while PTGX share price is 81.93, making it a Buy technically.
-
PTGX stock price is 81.93 and Protagonist Therapeutics, Inc. 200-day simple moving average is 7.91, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics, Inc.
Is Protagonist Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.44 per share, and a decrease next year of $2.52 per share.
Technical Analysis of Protagonist Therapeutics, Inc.
Should I short Protagonist Therapeutics, Inc. stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is 22.84, suggesting Protagonist Therapeutics, Inc. is a Buy
-
Protagonist Therapeutics, Inc. Relative Strength Index (RSI) is 46.2, which suggest Protagonist Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Protagonist Therapeutics, Inc. is (81.05 - 84.35), which suggest Protagonist Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics, Inc. is (73.25 - 88.77), which suggest Protagonist Therapeutics, Inc. is a Buy
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.